Disruptive technologies for proton/ion oncology workshop.

Europe/London
RAL

RAL

https://ukri.zoom.us/j/96067644318 R22, Pickavance Lecture Theatre Harwell Oxford Campus
Bob Bingham (STFC), Ken Long (Imperial Coll.)
Description

The present incidence of 17 million new cases per year globally predicted to increase to 27.5 million new cases per year by 2040. Radiotherapy (RT) is effective in cancer patients and is already involved in cancer cures. To increase the rate of diagnosis of cancer in the early, curative, stage implies an increasing need for therapeutic interventions including RT.

The use of novel beams with strikingly different characteristics has led to exciting evidence of enhanced therapeutic benefit, eg., therapy using very high dose per fraction, very high dose rate (> 40 Gy/s, "FLASH"), and “mini-beam” (MBRT). This evidence, together with developments in our understanding of personalised medicine based on the biology of individual tumours, now provides the impetus for a radical transformation of ion beam therapy (IBT).

While incremental development of cyclotron-, synchrotron-, and linac-based solutions are being pursued to enhance clinical capability, laser-driven proton and ion sources are disruptive technologies that offer enormous potential to satisfy the anticipated growth in demand for IBT by providing more flexible, compact and cost-effective high energy particle sources.

In this workshop we will discuss the state of the art in the provision of IBT and various approaches by which to deliver the step change in capability required to meet the projected growth in demand.

Hybrid Event

Registration
Registration
Participants
  • Ajit Kurup
  • Amato Giaccia
  • Anna Ward
  • Ben Cline
  • Ben Cox
  • Choiphy Zhao
  • Christopher Baker
  • Claus Schmitzer
  • David Kelliher
  • Edgars Mamis
  • Elisabetta Boella
  • Erika Korobeinikova
  • Frank Zhang
  • Hannah Norman
  • Hywel Owen
  • Jacinta Yap
  • Jake Flowerdew
  • Jason Parsons
  • Jim Clarke
  • Josie McGarrigle
  • Katia Parodi
  • Ken Long
  • Kevin Prise
  • LAIMONAS JARUSEVICIUS
  • Luke Dyks
  • Maja Khalid-Effiom
  • Manjit Dosanjh
  • Maria Maxouti
  • Nicholas Dover
  • Nicolas Bourgeois
  • Oliver Ettlinger
  • Paul Kyberd
  • Peter Gruebling
  • PETER RATOFF
  • Phil Allport
  • Philip Burrows
  • Raja Sekhar Savanam
  • Rakesh Kumar Yembadi
  • Rob Murphy
  • Robert Bingham
  • Rohan Prasad
  • Ruth Bamford
  • Ruth McLauchlan
  • Simon Jolly
  • Stan Botchway
  • Stuart Green
  • Suzie Sheehy
  • Tehelj -
  • Tim Greenshaw
  • Titus-Stefan Dascalu
  • Ulrich Schramm
  • Vessela Vassileva
  • William Shields
  • Ziyu Huang
    • 10:00 10:30
      Registration: Tea & Coffee 30m

      Tea and coffee in R22 coffee lounge

    • 10:30 12:30
      Session 1: Clinical need; pre-clinical and biological research
      Convener: Ken Long (Imperial Coll.)
      • 10:30
        Karen Kirkby (University of Manchester) 30m

        Lessons learned in building a research capability for proton therapy; informing the design of the ITRF

      • 11:00
        Katia Parodi (LMU) 30m

        Advanced on-site imaging in modern radiation therapy: challenges and opportunities

      • 11:30
        Jason Parsons (University of Liverpool) 30m

        Radiobiology research examining the impact of protons versus photons in tumour cell models

      • 12:00
        Kristoffer Petersson (OIRO) 30m

        FLASH, current status and potential for proton/ion oncology

    • 12:30 14:00
      Lunch Break 1h 30m
    • 14:00 15:00
      RAL Lecture: RAL Lecture by Amato Giacca and Ken Long
    • 15:00 15:29
      Coffee & Tea 29m
    • 15:30 17:35
      Session 2: New and transformational approaches
      Convener: Bob Bingham (STFC)
      • 15:30
        Ulrich Schramm (HZDR) 30m
      • 16:00
        Nick Dover (IC/JAI) 30m

        Development of laser ion sources toward applications in oncology

      • 16:30
        Hywel Owen (ASTeC/DL) 30m

        A preliminary activity to prepare for a UK Ion Therapy Research facility

      • 17:00
        Kevin Prise (QUB) 30m

        Pushing the dose-rate envelope with laser-based radiobiology

    • 17:35 18:05
      Closing Discussion